Two popular medications used in the fight against obesity—semaglutide (Wegovy; Novo Nordisk) and tirzepatide (Zepbound; Eli Lilly)—are priced too high to be considered cost-effective by currently ...

Discover what avoidable costs are, how they benefit businesses, and real-world examples of strategies to minimize expenses and boost financial flexibility.

In patients with muscle-invasive bladder cancer, trimodal therapy modestly improved quality of life compared with radical cystectomy but was not cost-effective at either 5 or 10 years. The high costs ...

Companies that provide competitive employee benefits may have an easier time attracting and retaining talent. Health insurance is an essential benefit, and many employers want to provide their ...

A multicomponent exercise program that includes strength, aerobic, agility, and balance training exercises is cost-effective and results in improved cognition among stroke survivors, compared with a ...

Wegovy (semaglutide) is an injectable prescription weight loss medicine that has helped people with obesity. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) For those who are ...

Employers are preparing for the steepest rise in health benefit costs in more than a decade. According to Mercer's 2025 National Survey of Employer-Sponsored Health Plans, total health benefit costs ...

We're rounding up what benefit leaders had to say about the top workplace trends of 2025. See part 1 on RTO mandates here. Processing Content Healthcare costs are rising at their fastest pace in more ...

Amid a yearslong wave of enthusiasm and uptake for Eli Lilly and Novo Nordisk's blockbuster obesity medicines, the drugs have scored a strong endorsement from an independent U.S. cost watchdog. In a ...